Patents
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
02/2011
02/23/2011CN101981036A Pyrrolo [2, 3-D] pyridines and use thereof as tyrosine kinase inhibitors
02/23/2011CN101981035A Triazolium salts as PAR1 inhibitors, production thereof, and use as medicaments
02/23/2011CN101981034A Triazolopyridazines as PAR1 inhibitors, production thereof, and use as medicaments
02/23/2011CN101981033A Substituted imidazopyridazines useful as kinase inhibitors
02/23/2011CN101981032A Substituted arylamide diazepinopyrimidone derivatives for the treatment of neurodegenerative diseases caused by abnormal activity of GSK3-beta
02/23/2011CN101981031A Tricyclic compounds having corticotropin-releasing factor antagonistic activity and pharmaceutical compositions containing them
02/23/2011CN101981030A Dihydro- 1H- pyrrolo [1,2-a] indol-1-yl carboxylic derivatives which act as S1P1 agonists
02/23/2011CN101981025A Diarylmethylamide derivative having antagonistic activity on melanin-concentrating hormone receptor
02/23/2011CN101980711A Aromatic heterocyclic fused indolobenzadiazepine HCV NS5B inhibitors
02/23/2011CN101302218B Preparation of Trandolapril diketone
02/22/2011US7893280 2,4-disubstituted thiazolyl derivatives
02/22/2011US7893277 Poly(ethylene glycol) containing chemically disparate endgroups
02/22/2011US7893085 3-(4-Bromo-2-fluoro-phenylamino)-thieno[3,2-c]pyridine-2-carboxylic acid (2,2-dimethyl-[1,3]dioxolan-4-ylmethoxy)-amide; mitogen activated protein extracellular kinase kinase (MEK) inhibitor; antiproliferative, antiinflammatory agent
02/22/2011US7893068 Physiologically active substances
02/22/2011US7893058 Imidazolopyrazine compounds useful for the treatment of degenerative and inflammatory diseases
02/22/2011US7893051 Thiophenyl and pyrrolyl azepines as serotonin 5-HT2c receptor ligands and uses thereof
02/22/2011CA2553879C Viral polymerase inhibitors
02/22/2011CA2485909C Azepinoindole and pyridoindole derivatives as pharmaceutical agents
02/22/2011CA2474823C Heteroaryl substituted 2-pyridinyl and 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a] pyrimidin-4-one derivatives
02/17/2011WO2011019986A2 Processes for preparing pemetrexed
02/17/2011WO2011019405A1 Pyrimidine compounds as tuberculosis inhibitors
02/17/2011WO2011018994A1 Phthalocyanine compound, preparation method therefor, and coloring composition including said phthalocyanine compound
02/17/2011WO2011018894A1 Pyrrolopyrimidine derivatives as potassium channel modulators
02/17/2011WO2011018495A1 New compounds for the treatment of cns disorders
02/17/2011WO2011018494A1 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2, 4, 5-trifluorphenyl)butyl]-5, 6, 7, 8-tetrahydro-3-(tri fluormethyl)-1, 2, 4 -triazolo[4,3-a]pyrazine
02/17/2011WO2011018454A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
02/17/2011US20110040088 Fused heterocyclic compounds
02/17/2011US20110040087 Peptide turn mimetics
02/17/2011US20110039856 Polymorphs of a c-met/hgfr inhibitor
02/17/2011US20110039838 Pyrrolotriazine compounds as kinase inhibitors
02/17/2011US20110039836 Tricyclic antibiotics
02/17/2011US20110039835 Substituted arylamide diazepinopyrimidone derivatives
02/17/2011US20110039831 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives
02/17/2011US20110039825 Ligands of alpha-adrenoceptors, dopamine, histamine, imidazoline and serotonin receptors and their use
02/17/2011US20110039824 1,2,3,6-tetrahydroazepino[4,5-b]indole-5-carboxylate nuclear receptor inhibitors
02/17/2011US20110038876 Heterocyclic compounds and use thereof as erk inhibitors
02/17/2011US20110038835 Anilides and analogs as rho kinase inhibitors
02/17/2011CA2771011A1 Crystalline compound of 7-[(3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine
02/17/2011CA2770873A1 Heterocyclic hydrazone compounds and their uses to treat cancer and inflammation
02/16/2011EP2284920A1 Compound for organic electric field light-emitting element and organic electric field light-emitting element
02/16/2011EP2284172A1 Immunomodulating heterocyclic compounds
02/16/2011EP2284171A1 Amides of diazabicycloalkanes selective for nicotinic acetylcholine receptor sub-types
02/16/2011EP2283021A2 Switchable special effect substances
02/16/2011EP2283020A1 Substituted imidazopyr-and imidazotri-azines
02/16/2011EP2283019A1 Gpr119 receptor agonists
02/16/2011EP2283018A1 Hepatitis c virus inhibitors
02/16/2011EP2283017A1 Fused pyrimidineone compounds as trpv3 modulators
02/16/2011EP2283016A1 Thiophenyl-substituted 2-imino-3-methyl pyrrolo pyrimidinone compounds as bace-1 inhibitors, compositions, and their use
02/16/2011EP2283004A1 Amido-thiophene compounds and their use
02/16/2011EP1723151B1 Pyrrolobenzodiazepines as key intermediates in the synthesis of dimeric cytotoxic pyrrolobenzodiazepines
02/16/2011CN101977915A Macrocyclic serine protease inhibitors
02/16/2011CN101977914A Compounds for the treatment of hepatitis c
02/16/2011CN101977913A Pyrrolo[2,3-d]pyrimidin-2-yl-amine derivatives as pkc-theta inhibitors
02/16/2011CN101977912A Mtor inhibitor salt forms
02/16/2011CN101977655A Indazole derivatives
02/16/2011CN101974030A Preparation method of ammonium glyphosate technical product
02/16/2011CN101974000A Method for separating four isomers of tetra(o-aminophenyl)porphyrin
02/16/2011CN101973999A Trimethoxysulfydrylporphyrin with carbon chain length being 6
02/16/2011CN101973998A Pyrrolopyrimidine A2b selective antagonist compounds, their synthesis and use
02/16/2011CN101973997A Method for preparing sitagliptin phosphate side chain
02/16/2011CN101973996A Imide biotin intermediate monoester and preparation method and use thereof
02/16/2011CN101972675A Cobalt sulfonated phthalocyanine desulfurization catalyst and preparation method thereof
02/16/2011CN101262041B Application of dissoluble tetraalkylammonium axial phthalocyanine compound replacement in making organic film transistor
02/15/2011US7888505 6,7-dihydrobenzimidazo[1,2-c]quinazolin-6-one carboxylic acids, their esters, and methods of synthesis thereof
02/15/2011US7888502 Titanyl phthalocyanine processes and photoconductors thereof
02/15/2011US7888501 Process for making organic photosensitive pigment
02/15/2011US7888371 Use of triazolopyrimidine derivatives as microbicides
02/15/2011US7888359 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
02/15/2011US7888357 Anti-inflammatory and protein kinase inhibitor compositions and related methods for downregulation of detrimental cellular responses and inhibition of cell death
02/15/2011US7888356 Antibiotics containing borinic acid complexes and methods of use
02/15/2011US7888349 Piperazine, [1,4]Diazepane, [1,4]Diazocane, and [1,5]Diazocane fused imidazo ring compounds
02/15/2011US7888347 Pyrazolo [3,4-D]azepine derivatives as histamine H3 antagonists
02/15/2011US7888343 Substituted, bicyclic 8-pyrrolidinoxanthines, and methods for their use as inhibitors of dipeptidyl peptidase
02/15/2011US7888285 2,4,6-phenyl substituted cyclic ketoenols
02/15/2011CA2558272C Pyridone derivative
02/15/2011CA2496842C Heterocyclic aromatic compounds useful as growth hormone secretagogues
02/15/2011CA2481460C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, their preparation and their application in therapeutics
02/15/2011CA2470067C Imidazoquinoline derivatives
02/15/2011CA2325937C Peptide turn mimetics
02/10/2011WO2011017342A2 Mesoionic pesticides
02/10/2011WO2011017334A2 Mesoionic pesticides
02/10/2011WO2011017299A2 PROCESS FOR PREPARING A 2-ALKYNYL SUBSTITUTED 5-AMINO-PYRAZOLO-[4,3-e]-1,2,4-TRIAZOLO[1,5-c]PYRIMIDINE
02/10/2011WO2011017108A2 Cyclopropyl modulators of p2y12 receptor
02/10/2011WO2011017009A1 Novel azaheterocyclic compounds
02/10/2011WO2011016648A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
02/10/2011WO2011016576A1 Alanine derivatives as inhibitors of apoptosis proteins
02/10/2011WO2011016016A1 Processes for the preparation of vardenafil
02/10/2011WO2011015652A1 3-heteroarylmethyl-imidazo[1,2-b]pyridazin-6-yl derivatives as c-met tyrosine kinase modulators
02/10/2011WO2011015343A1 Metabotropic glutamate receptor modulators
02/10/2011WO2010068810A3 Certain substituted amides, method of making, and method of use thereof
02/10/2011US20110034475 1-aza-bicyclo[3.3.1]nonanes
02/10/2011US20110034473 Novel (pyrroloquinoxalinyl) pyrazinecarbohydrazide-oxalic acid co-crystal for treatment of cancer and other diseases
02/10/2011US20110034472 Novel Compounds for Treatment of Cancer and Disorders Associated With Angiogenesis Function
02/10/2011US20110034468 Triazolo compounds useful as dgat1 inhibitors
02/10/2011US20110034467 Dihydro-pyrrolopyridine-, dihydro-pyrrolopyridazine- and dihydro-pyrrolopyrimidine-derivatives and use thereof
02/10/2011US20110034456 Imidazopyridazines as par1 inhibitors, production thereof, and use as medicaments
02/10/2011US20110034452 Triazolium salts as par1 inhibitors, production thereof, and use as medicaments
02/10/2011US20110034451 Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
02/10/2011US20110034440 Homocysteine synthase inhibitor
02/10/2011US20110034438 Structural mimetics of proline-rich peptides and the pharmaceutical use thereof